Milis SIGNED

Project "Milis" data sheet

The following table provides information about the project.

 Partnership

Take a look of project's partnership.

Map

 Project objective

Excess sugar consumption is a major contributor to the alarming rates of obesity, diabetes, and dental disease that exist in many developed countries. According to the Credit Suisse Research Institute, close to 400M people worldwide are affected by Type II Diabetes. 4.8M people die of chronic disease every year, a number that is quickly rising. Costs to the global healthcare system are estimated at a staggering $470B per year, representing 10% of all the healthcare costs. Artificial sweeteners offer a non-caloric alternative to sugar but have health concerns of their own, and are not always effective in maintenance of a healthy diet. However their use is not totally safe. Saccharine, for example, previously used on a large scale, was abandoned as soon as it was linked with development of bladder cancer. Artificial sweetener consumption modulates the gut microbiota and raises the risk of glucose intolerance. Sweet proteins that occur naturally in some tropical plants can have a sweetness a thousand times that of sucrose. This indicates that proteins potentially represent novel lowcalorie, nutritious sweeteners – superior to either sugar or artificial sweeteners. However, producing naturally occurring sweet proteins on a large scale is challenging and limitations of their physicochemical properties will constrain their application in the food industry. Milis Bio developed “Milis”, a novel protein which will be 200 - 500 times sweeter than sugar per gram. Milis presents low caloric content, no aftertaste, and no unhealthy chemical components. Milis allows the consumer to think only about how great their food tastes, rather than worrying about what’s in it. Using a protein as a flavouring guarantees that the ingredient will be low-calorie, easily digestible, and suitable for diabetics.